News

Delcath Systems, a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, has exceeded 90% enrollment (reaching 85 patients) for its

Sinochem Quanzhou Petrochemical (Sinochem Quanzhou) has selected UNIPOL Polypropylene Process Technology for its new 200 KTA polypropylene facility. The plant will be built in Quanzhou, Fujian Province in

ISTA Pharmaceuticals (ISTA) has reported positive preliminary phase 3 results from the company’s Xibrom (bromfenac ophthalmic solution) 0.09% QD (once-daily) confirmatory clinical study. Xibrom 0.09% QD achieved statistical

Seattle Genetics has completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma. The company has said that Brentuximab vedotin is

Zargis Medical has started selling Zargis Cardioscan heart sound analysis software, along with 3M’s just-released Bluetooth-enabled 3M Littmann Electronic Stethoscope Model 3200, as part of its previously announced

CSL Biotherapies has announced the initiation of the company’s first US clinical trials of its candidate Influenza A/H1N1 2009 vaccine. The studies are expected to determine the safety

Osteologix, a Virginia-based biopharmaceutical company working in the area of musculoskeletal diseases, such as osteoporosis, has announced that the Japan Patent Office (JPO) has issued a Decision to

CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, has announced that study results demonstrated that arimoclomol exhibited both statistically significant

Santaris has signed a multi-year worldwide strategic alliance with Shire to discover and develop new RNA-based medicines to treat rare genetic disorders. The alliance will use Santaris’ proprietary